Advances in clinical chemistry. (notice n° 28115)
| 000 -LEADER | |
|---|---|
| fixed length control field | 05732cam a2200649Mi 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn851971988 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211202094857.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130706s2013 vtu o 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | EBLCP |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | EBLCP |
| Modifying agency | OCLCQ |
| -- | OPELS |
| -- | N$T |
| Description conventions | rda |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780124078277 (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0124078273 (electronic bk.) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)851971988 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RB40 |
| Item number | .A383 2013eb |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | HEA |
| Subject category code subdivision | 039000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 014000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 022000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 112000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 045000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.0756 |
| Edition number | 23 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | TEFA |
| 245 00 - TITLE STATEMENT | |
| Title | Advances in clinical chemistry. |
| Number of part/section of a work | Volume 61 / |
| Statement of responsibility, etc | edited by Gregory S. Makowski. |
| 264 #1 - | |
| -- | Burlington : |
| -- | Elsevier Science, |
| -- | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (241 pages). |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 347 ## - | |
| -- | data file |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Advances in Clinical Chemistry |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Front Cover; Advances in Clinical Chemistry; Copyright; Contents; Contributors; Preface; Chapter One: BNP Molecular Forms and Processing by the Cardiac Serine Protease Corin; 1. Introduction; 2. BNP Molecular Forms: Implications for Biomarker and Therapeutic Use in Cardiovascular Disease; 2.1. Background; 2.2. BNP signal peptide; 2.3. NT-proBNP1-76 and BNP1-32; 2.4. Degradation products: BNP3-32, BNP5-32, and smaller peptides; 2.5. ProBNP1-108; 3. BNP Paradox in Heart Failure; 4. BNP Processing and Propeptide Convertases; 5. Cardiac Serine Protease, Corin; 5.1. Expression and function. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 5.1.1. General information under physiologic conditions5.1.2. Animal models; 5.1.3. Human corin single-nucleotide polymorphism; 5.1.4. Human disease states and gender differences; 5.2. Other topics; 5.2.1. BNP processing in the circulation; 5.2.2. Role of glycosylation on BNP molecular forms and processing; 6. Clinical Implication and Future Directions; Acknowledgments; References; Chapter Two: Current Applications of Cardiac Troponin T for the Diagnosis of Myocardial Damage; 1. Introduction; 2. Biology and Function; 2.1. History; 2.2. Cardiac myofibrillar apparatus. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 2.3. Troponin complex function2.4. Troponin isoforms; 2.5. Myocardial ischemia and necrosis; 3. Troponin Assays; 3.1. History; 3.2. Principle of test; 3.3. Cutoffs and sensitivity; 3.4. Preanalytic factors; 3.5. Assay standardization; 4. TnT Clinical Applications; 4.1. Myocardial necrosis; 4.1.1. AMI with ST-segment elevation; 4.1.2. Acute coronary syndromes without persistent STEMIs (unstable angina and non-ST-segment myocardial infarction); 4.1.3. Differential diagnosis of increased troponin; 4.1.4. Practical recommendations for use; 4.2. Pulmonary artery embolism. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.3. Pulmonary artery hypertension4.4. Heart failure; 4.5. Cardiomyopathies; 4.5.1. Dilated cardiomyopathy; 4.5.2. Hypertrophic cardiomyopathy; 4.5.3. Other cardiomyopathies; 4.6. Arrhythmias; 4.7. Cardiotoxicity induced by anticancer therapy; 4.7.1. Diagnostic methods; 4.7.2. Cardiac troponins; 5. Biologic Variability; 6. Conclusion; Acknowledgments; References; Chapter Three: Markers in Nonalcoholic Steatohepatitis; 1. Introduction; 2. Epidemiology and Associated Conditions; 3. Pathogenesis and Histological Features; 4. Clinical and Diagnostic Approach; 5. Liver Function Tests. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 6. Adipokines, Endocrine Mediators, and Signaling Networks in NASH7. Cytokines and Inflammation Biomarkers; 8. Oxidative Stress Markers; 9. Noninvasive Serum Biomarkers of Fibrosis; 9.1. Indirect markers of fibrosis; 9.2. Direct markers of fibrosis; 9.2.1. Markers associated with matrix deposition; 9.2.2. Markers associated with matrix degradation; 9.3. Cytokines and other markers associated with hepatic fibrosis; 9.4. Diagnostic panels to assess NASH; 10. Potential Genetic Modifiers and Novel Markers; 11. Conclusion; References. |
| 500 ## - GENERAL NOTE | |
| General note | Chapter Four: The Expanding Role of Tandem Mass Spectrometry in Optimizing Diagnosis and Treatment of Thyroid Disease. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Volume 61 in the internationally acclaimed Advances in Clinical Chemistry contains chapters submitted from leading experts from academia and clinical laboratory science. Authors are from a diverse field of clinical chemistry disciplines and diagnostics, ranging from basic biochemical exploration to cutting-edge microarray technology. Written by authors representing the diverse field of clinical chemistry and diagnostics, reviews in Advances in Clinical Chemistry cover a range of cutting-edge research ranging from basic biochemical exploration to microarray technolog. |
| 500 ## - GENERAL NOTE | |
| General note | Includes index. |
| 588 ## - | |
| -- | Description based on print version record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Clinical chemistry. |
| 9 (RLIN) | 38245 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | HEALTH & FITNESS / Diseases / General |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38246 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Clinical Medicine |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38247 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Diseases |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38248 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Evidence-Based Medicine |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38249 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Internal Medicine |
| Source of heading or term | bisacsh |
| 9 (RLIN) | 38250 |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 9 (RLIN) | 20 |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Makowski, Gregory S. |
| Fuller form of name | (Gregory Stephen) |
| 9 (RLIN) | 4654 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| Main entry heading | Makowski, Gregory. |
| Title | Advances in Clinical Chemistry. |
| Place, publisher, and date of publication | Burlington : Elsevier Science, ©2013 |
| International Standard Book Number | 9780124076808 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Advances in Clinical Chemistry. |
| 9 (RLIN) | 2504 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://www.sciencedirect.com/science/book/9780124076808">http://www.sciencedirect.com/science/book/9780124076808</a> |
| 938 ## - | |
| -- | EBL - Ebook Library |
| -- | EBLB |
| -- | EBL1214328 |
| 938 ## - | |
| -- | EBSCOhost |
| -- | EBSC |
| -- | 593381 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Ebook |
| 956 ## - LOCAL ELECTRONIC LOCATION AND ACCESS (OCLC) | |
| Electronic name | Consortium |
| 994 ## - | |
| -- | C0 |
| -- | TEF |
Pas d'exemplaire disponible.
